Senior Medical Science Liaison, Medical Affairs
The VIOS Clinic · Manhattan, NY · 1 wk ago
On-siteAnalystFull-time
Role: Medical Science Liaison (MSL)/Senior MSL, specializing in gynaecological malignancies, responsible for scientific engagement with healthcare professionals and key opinion leaders across Europe/Rest of World (EUR/RoW). Key Responsibilities Act as a local expert by maintaining up-to-date knowledge of Genmab’s products, clinical landscape, and competitive environment.Establish and nurture scientific relationships with healthcare professionals to facilitate medical and scientific exchanges.Provide balanced clinical and scientific information regarding Genmab’s assets and gather insights to inform clinical development and strategic initiatives.Represent the company at medical conferences and support engagement with health technology agencies and payers.Support clinical trials by collaborating with development teams, assisting in investigator engagement, and facilitating trial proposals.Develop and execute territory plans aligned with global and regional objectives, and contribute to publication planning.Support internal training and foster effective cross-functional collaborations. Qualifications & Skills Advanced scientific/medical degree (PharmD, PhD, MD) or relevant clinical background.Minimum 2 years of MSL/Medical Affairs experience, preferably in gynecologic oncology, with clinical trial knowledge a plus.Strong communication, presentation, and interpersonal skills with high integrity and patient-centric focus.Ability to work independently and collaboratively, with flexibility and a positive attitude.Fluency in German and English, proficiency in MS Office and business applications.Knowledge of compliance regulations such as EFPIA, IFPMA, and FSA-Kodex. Additional Information: This role involves significant travel (60%) and offers a competitive salary range, with benefits supporting well-being, training, and development. The position emphasizes a culture of innovation, collaboration, and integrity, aiming to improve patient outcomes through groundbreaking antibody therapies.